Abstract
The objective of this was to summarize the efficacy and safety of iodine-125 seed implantation in the treatment of sacrococcygeal chordoma. CT-guided implantation of radioactive iodine-125 seed was applied in treating a patient with sacrococcygeal chordoma. The incidence of complications was recorded and the results were evaluated and analyzed, to compare the postoperative complications and recurrence rate of sacrococcygeal chordoma. The patient was followed up to 15 months after operation. The minimum peripheral dose was 180 Gy, and 8 months after the implantation, the tumor mass was reduced significantly. There was no serious complications detected during the follow-up period. Radioactive iodine-125 seed implantation can improve the target volume dose, with the high doses of radioactive iodine-125 seed, the tumor, which was refractory and insensitive to chemotherapy and radiotherapy, can be effectively controlled and complications are less than surgical treatment. However, the long-term efficacy of this treatment needs further follow-up.
Similar content being viewed by others
References
Naka, T., Boltze, C., Kuester, D., et al. (2003). Skull base and nonskull base chordomas: Clinicopathologic and immunohistochemical study with special reference to nuclear pleomorphism and proliferative ability. Cancer, 98, 1934–1941.
Zhongnian C, Mingchang S, Muyi G. (1997). Applied surgical pathology [M] (pp. 155–156). Shanghai: Shanghai Medical University Publishing House.
Bergh, P., Kindblom, L. G., Gunterberg, B., et al. (2000). Prognostic factors in chordoma of the sacrum and mobile spine: A study of 39 patients. Cancer, 9, 2122–2134.
McMaster, M. L., Goldstein, A. M., Bromley, C. M., et al. (2001). Chordoma: Incidence and survival patterns in the United States, 1973–1995. Cancer Causes and Control, 12(1), 1–11.
Yonemoto, T., Tatezaki, S., Takenouchi, T., et al. (1999). The surgical management of sacrococcygeal chordoma. Cancer, 85(4), 878–883.
Weibo, Y., & Zihao, Y. (2008). Tumor therapeutic radiology [M] (p. 1145). Beijing: Peking Union Medical College Publishing House.
Yamaguchi, T., Watanabe-Ishiiwa, H., Suzuki, S., et al. (2005). Incipient chordoma: A report of two cases of early-stage chordoma arising from benign notochordal cell tumors. Modern Pathology, 18(7), 1005–1010.
Dehong, Y. (1997). Modern anorectal surgery [M] (pp. 364–365). Beijing: People’s Military Medicine Press.
Fuchs, B., Dickey, I. D., Yaszemski, M. J., et al. (2005). Operative management of sacral chordoma. Journal of Bone and Joint Surgery. American Volume, 87(10), 2211–2216.
Simpson, A. H., Porter, A., Davis, A., et al. (1995). Cephalad sacral resection with a combined extended ilioinguinal and posterior approach. Journal of Bone and Joint Surgery. American Volume, 77(3), 405–411.
Todd, L. T., Jr, Yaszemski, M. J., Currier, B. L., et al. (2002). Bowel and bladder function after major sacral resection. Clinical Orthopaedics and Related Research, 397, 36–39.
Wuisman, P., Lieshout, O., van Dijk, M., et al. (2001). Reconstruction after total en bloc sacrectomy for osteosarcoma using a custom-made prosthesis: A technical note. Spine (Phila Pa 1976), 26(4), 431–439.
Weinberger, P. M., Yu, Z., Kowalski, D., et al. (2005). Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. Archives of Otolaryngology—Head and Neck Surgery, 131(8), 707–711.
Samson, I. R., Springfield, D. S., Suit, H. D., et al. (1993). Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. Journal of Bone and Joint Surgery. American Volume, 75(10), 1476–1484.
Hulen, C. A., Temple, H. T., Fox, W. P., et al. (2006). Oncologic and functional outcome following sacrectomy for sacral chordoma. Journal of Bone and Joint Surgery. American Volume, 7, 1532–1539.
York, J. E., Kaczaraj, A., Abi-Said, D., et al. (1999). Sacral chordoma: 40-Year experience at a major cancer center. Neurosurgery, 44, 74–79.
Gang, L., & Yang, C. (2008). The treatment of sacral tumors. Orthopedic Journal of China, 17, 1322–1325.
Kongwu, C., et al. (2009). Analysis of recurrence factors of Sacral chordoma. Orthopedic Journal of China, 17(21), 1613–1616.
Hanna, S. A., Aston, W. J. S., Briggs, T. W. R., et al. (2008). Sacral chordoma: Can local recurrence after sacrectomy be predicted. Clinical Orthopaedics and Related Research, 466, 2217–2223.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ni, Rh., Wang, G., Zhang, Zm. et al. Iodine-125 Seed Implantation in the Treatment of Sacrococcygeal Chordoma: A Case Report. Cell Biochem Biophys 64, 107–113 (2012). https://doi.org/10.1007/s12013-012-9378-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-012-9378-6